ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Wynder To Receive Distinguished Achievement Award From ASPO; Brown Heads council Of Deans

February 24, 1984

House Committee Urges “Heat Shock” Cancer Center, But Can It Be Done?

July 24, 1998

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980

In Brief: Pardee, Durant Head AASR, ASCO; Sartorell, Hellman Presidents Elect; ONS Reelects Johnson

May 31, 1985